Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Fc-γ receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancerLiu, G.; Tu, D.; Lewis, M.; Cheng, D.; Sullivan, L.; Chen, Z.; Morgen, E.; Simes, J.; Price, T.; Tebbutt, N.; Shapiro, J.; Jeffery, G.; Mellor, J.; Mikeska, T.; Virk, S.; Shepherd, L.; Jonker, D.; O'Callaghan, C.; Zalcberg, J.; Karapetis, C.; et al.
2016Advances in molecular pathology and treatment of periampullary cancersChandrasegaram, M.; Chen, J.; Price, T.; Zalcberg, J.; Sjoquist, K.; Merrett, N.
2016Metastatic colorectal cancer in young adults: a study from the South Australian Population-Based RegistryVatandoust, S.; Price, T.; Ullah, S.; Roy, A.; Beeke, C.; Young, J.; Townsend, A.; Padbury, R.; Roder, D.; Karapetis, C.
2016Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancerPrice, T.; Kim, T.W.; Li, J.; Cascinu, S.; Ruff, P.; Suresh, A.S.; Thomas, A.; Tjulandin, S.; Guan, X.; Peeters, M.
2016Selective internal radiation therapy for liver metastases from colorectal cancerTownsend, A.; Chong, L.; Karapetis, C.; Price, T.
2016Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitroDorward, H.; Du, A.; Bruhn, M.; Wrin, J.; Pei, J.; Evdokiou, A.; Price, T.; Yool, A.; Hardingham, J.
2016Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancerTie, J.; Wang, Y.; Tomasetti, C.; Li, L.; Springer, S.; Kinde, I.; Silliman, N.; Tacey, M.; Wong, H.; Christie, M.; Kosmider, S.; Skinner, I.; Wong, R.; Steel, M.; Tran, B.; Desai, J.; Jones, I.; Haydon, A.; Hayes, T.; Price, T.; et al.
2016Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderlyRoder, D.; Karapetis, C.; Wattchow, D.; Moore, J.; Singhal, N.; Joshi, R.; Keefe, D.; Fusco, K.; Powell, K.; Eckert, M.; Price, T.
2016MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trialGormly, K.L.; Coscia, C.; Wells, T.; Tebbutt, N.; Harvey, J.A.; Wilson, K.; Schmoll, H.J.; Price, T.
2016Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerSchofield, P.; Stockler, M.; Zannino, D.; Tebbutt, N.; Price, T.; Simes, R.; Wong, N.; Pavlakis, N.; Ransom, D.; Moylan, E.; Underhill, C.; Wyld, D.; Burns, I.; Ward, R.; Wilcken, N.; Jefford, M.